Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$79.30
-0.5%
$79.30
$64.89
$82.62
$154.63M1.225,496 shs3,870 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
$0.12
$0.07
$1.42
$2.80M1.973.36 million shs528,287 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
-0.45%+2.37%-1.23%+2.81%+18.52%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+0.52%-7.50%-43.61%-52.62%+7,769,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
0.00
N/A$87.2910.07% Upside
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.19N/AN/A$0.12 per share0.65

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/A11.74N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.11N/A-65.46%-150.14%-53.48%5/28/2024 (Estimated)

Latest NBY, C4XD, SUD, and FAB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$1.481.87%N/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Latest NBY, C4XD, SUD, and FAB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2024
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
Quarterly$0.24303/21/20243/22/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
23.25%

Insider Ownership

CompanyInsider Ownership
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
1.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
147,0001.95 millionN/ANot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million35.59 millionNot Optionable

NBY, C4XD, SUD, and FAB Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

First Trust Multi Cap Value AlphaDEX Fund logo

First Trust Multi Cap Value AlphaDEX Fund

NASDAQ:FAB
The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.